Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: KTN, NYX, JYZ, WB, AYD, KG, AP, and TSh have nothing relevant to disclose. LH is a consultant for a number of companies that are developing novel diagnostic and therapeutic options for diabetes treatment. He is a shareholder of the Profil Institut für Stoffwechselforschung GmbH, Kaarst, Germany. EPK is the President of WNWN International Inc., a medical waste management company in Burlington, Connecticut. He is currently a consultant for Stericycle, Daniels, HealthBeacon, and Tesalys. TSt is an Innovation Project Manager for ConvaTec Infusion Care. DAS is a sustainability consultant for multiple companies. RB is a Director at the South Bayside Waste Management Authority (SBWMA). However, he is not representing the official position of the SBWMA. LB is the CEO of “Déchets d’Activités de Soins à Risque Infectieux” (DASTRI) perforants, a French Health Industry Coalition for Sharps in Paris, France. DCK is a consultant for EoFlow, Fractyl, Integrity Applications, Lifecare, Novo, Roche Diagnostics, and Thirdwayv.